NO177186C - Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner - Google Patents
Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridinerInfo
- Publication number
- NO177186C NO177186C NO913188A NO913188A NO177186C NO 177186 C NO177186 C NO 177186C NO 913188 A NO913188 A NO 913188A NO 913188 A NO913188 A NO 913188A NO 177186 C NO177186 C NO 177186C
- Authority
- NO
- Norway
- Prior art keywords
- dihydropyridines
- enantiomerically pure
- polysubstituted
- preparation
- racemic
- Prior art date
Links
- YNGDWRXWKFWCJY-UHFFFAOYSA-N 1,4-Dihydropyridine Chemical class C1C=CNC=C1 YNGDWRXWKFWCJY-UHFFFAOYSA-N 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 2
- 239000002253 acid Substances 0.000 abstract 2
- 150000007513 acids Chemical class 0.000 abstract 2
- 238000007796 conventional method Methods 0.000 abstract 1
- 150000002541 isothioureas Chemical class 0.000 abstract 1
- -1 isothioureido groups Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical class NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 abstract 1
- 230000009466 transformation Effects 0.000 abstract 1
- 238000000844 transformation Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
- C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Plural Heterocyclic Compounds (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT8919477A IT1230752B (it) | 1989-02-17 | 1989-02-17 | Processo per la preparazione di 1,4 diidropiridine polisostituite in forma enantiomericamente pura. |
| PCT/EP1990/000243 WO1990009376A1 (en) | 1989-02-17 | 1990-02-15 | A process for preparation of enantiomerically pure polysubstituted 1,4-dihydropyridines |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO913188D0 NO913188D0 (no) | 1991-08-15 |
| NO913188L NO913188L (no) | 1991-08-15 |
| NO177186B NO177186B (no) | 1995-04-24 |
| NO177186C true NO177186C (no) | 1995-08-02 |
Family
ID=11158352
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO913188A NO177186C (no) | 1989-02-17 | 1991-08-15 | Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5245039A (it) |
| EP (2) | EP0458823B1 (it) |
| JP (1) | JPH04505610A (it) |
| KR (1) | KR0155557B1 (it) |
| AT (1) | ATE95813T1 (it) |
| AU (1) | AU630928B2 (it) |
| CA (1) | CA2047741A1 (it) |
| DE (1) | DE69003936T2 (it) |
| DK (1) | DK0458823T3 (it) |
| ES (1) | ES2060144T3 (it) |
| FI (1) | FI95371C (it) |
| HU (1) | HUT62270A (it) |
| IE (1) | IE66498B1 (it) |
| IT (1) | IT1230752B (it) |
| NO (1) | NO177186C (it) |
| RU (1) | RU2069658C1 (it) |
| WO (1) | WO1990009376A1 (it) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571827A (en) * | 1990-03-13 | 1996-11-05 | Sepracor Inc. | Methods and compositions for treating hypertension, angina and other disorders using optically pure s(-) nitrendipine |
| US5834496A (en) * | 1991-12-02 | 1998-11-10 | Sepracor, Inc. | Methods for treating hypertension using optically pure S(-) felodipine |
| WO1993010781A1 (en) * | 1991-12-02 | 1993-06-10 | Sepracor, Inc. | Methods and compositions for treating hypertension, angina, and other disorders using optically pure s(-) felodipine |
| ES2055652B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion de 2,6-dimetil-4-(2,3-diclorofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil. |
| ES2055655B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion de 2,6-dimetil-4-(2-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isobutil-5-metil. |
| ES2055654B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion de 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-etil-5-metil. |
| ES2055653B1 (es) * | 1992-09-22 | 1995-03-01 | Elmuquimica Farm Sl | Procedimiento de obtencion del 2,6-dimetil-4-(3-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-isopropil-5-(2-metoxi)etil. |
| GB9405833D0 (en) * | 1994-03-24 | 1994-05-11 | Pfizer Ltd | Separation of the enantiomers of amlodipine |
| FR2719585B1 (fr) * | 1994-05-05 | 1996-08-02 | Lafon Labor | Procédé d'obtention de 1,4-dihydropyridines optiquement pures. |
| US5554621A (en) * | 1995-06-07 | 1996-09-10 | Bristol-Myers Squibb Company | Dihydropyridine NPY antagonists: nitrogen heterocyclic derivatives |
| DE60128683T2 (de) * | 2000-04-11 | 2008-01-24 | Sankyo Co., Ltd. | Stabilisierte pharmazeutische zusammenstellungen die den calziumkanalblocker azelnidipine enthalten |
| ITMI20012434A1 (it) | 2001-11-20 | 2003-05-20 | Dompe Spa | Acidi 2-aril-propionici e composizioni farmaceutiche che li contengono |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3447169A1 (de) * | 1984-12-22 | 1986-07-03 | Bayer Ag, 5090 Leverkusen | Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln |
| KR930011486B1 (ko) * | 1985-08-06 | 1993-12-08 | 베링거 만하임 이탈리아 에스.피.에이. | 제약상 유효한 2-티오메틸-치환-1,4-디히드로피리딘 |
| EP0225175A3 (en) * | 1985-11-28 | 1988-12-28 | FISONS plc | Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof |
| US4920225A (en) * | 1986-12-22 | 1990-04-24 | Laboratoires Syntex S.A. | Resolution of 1,4-dihydropyridine derivatives |
| EP0343193A1 (de) * | 1987-03-27 | 1989-11-29 | Byk Gulden Lomberg Chemische Fabrik Gmbh | 1,4-dihydropyridine-enantiomere |
| WO1988007531A1 (fr) * | 1987-03-27 | 1988-10-06 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Nouveaux composes optiquement actifs |
-
1989
- 1989-02-17 IT IT8919477A patent/IT1230752B/it active
-
1990
- 1990-02-15 RU SU905001680A patent/RU2069658C1/ru active
- 1990-02-15 KR KR1019900702275A patent/KR0155557B1/ko not_active Expired - Fee Related
- 1990-02-15 AT AT90903015T patent/ATE95813T1/de not_active IP Right Cessation
- 1990-02-15 AU AU50904/90A patent/AU630928B2/en not_active Ceased
- 1990-02-15 WO PCT/EP1990/000243 patent/WO1990009376A1/en not_active Ceased
- 1990-02-15 US US07/743,415 patent/US5245039A/en not_active Expired - Fee Related
- 1990-02-15 HU HU901962A patent/HUT62270A/hu unknown
- 1990-02-15 EP EP90903015A patent/EP0458823B1/en not_active Expired - Lifetime
- 1990-02-15 DK DK90903015.7T patent/DK0458823T3/da active
- 1990-02-15 JP JP2503175A patent/JPH04505610A/ja active Pending
- 1990-02-15 DE DE90903015T patent/DE69003936T2/de not_active Expired - Fee Related
- 1990-02-15 ES ES90903015T patent/ES2060144T3/es not_active Expired - Lifetime
- 1990-02-15 EP EP90102951A patent/EP0383320A1/en not_active Withdrawn
- 1990-02-15 CA CA002047741A patent/CA2047741A1/en not_active Abandoned
- 1990-02-16 IE IE58490A patent/IE66498B1/en not_active IP Right Cessation
-
1991
- 1991-08-15 NO NO913188A patent/NO177186C/no unknown
- 1991-08-15 FI FI913861A patent/FI95371C/fi not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO1990009376A1 (en) | 1990-08-23 |
| ATE95813T1 (de) | 1993-10-15 |
| KR0155557B1 (ko) | 1998-11-16 |
| EP0458823A1 (en) | 1991-12-04 |
| EP0383320A1 (en) | 1990-08-22 |
| IE66498B1 (en) | 1996-01-10 |
| DE69003936D1 (de) | 1993-11-18 |
| AU5090490A (en) | 1990-09-05 |
| JPH04505610A (ja) | 1992-10-01 |
| NO913188D0 (no) | 1991-08-15 |
| CA2047741A1 (en) | 1990-08-18 |
| EP0458823B1 (en) | 1993-10-13 |
| AU630928B2 (en) | 1992-11-12 |
| RU2069658C1 (ru) | 1996-11-27 |
| FI913861A0 (fi) | 1991-08-15 |
| FI95371C (fi) | 1996-01-25 |
| NO913188L (no) | 1991-08-15 |
| IE900584L (en) | 1990-08-17 |
| DE69003936T2 (de) | 1994-03-31 |
| IT1230752B (it) | 1991-10-29 |
| KR910700234A (ko) | 1991-03-14 |
| NO177186B (no) | 1995-04-24 |
| ES2060144T3 (es) | 1994-11-16 |
| IT8919477A0 (it) | 1989-02-17 |
| HUT62270A (en) | 1993-04-28 |
| FI95371B (fi) | 1995-10-13 |
| US5245039A (en) | 1993-09-14 |
| DK0458823T3 (da) | 1994-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO177186C (no) | Fremgangsmåte ved fremstilling av enantiomert rene polysubstituerte 1,4-dihydropyridiner | |
| NO20083728L (no) | Analogifremgangsmate for fremstilling av et terapeutisk aktivt nukleosid | |
| DE3851070D1 (de) | Verfahren zur Herstellung eines Oxid-Verbindungssupraleiterfadens. | |
| IT1217658B (it) | Processo perfezionato per la produzione di perfluoropolieteri costituiti sostanzialmente da unita' perfludossietilenche e perfluoroossipropileniche | |
| DE69311000D1 (de) | Verfahren zur Herstellung von mit Alpha-Anomeren angereicherten 1-Halogen-2-Deoxy-2,2-Difluor-D-Ribofuranosyl-Derivaten | |
| DE68916754D1 (de) | Verfahren zur Herstellung von optisch aktiver 3-Hydroxybuttersäure. | |
| PT92603A (pt) | Processo de producao de factor de crescimento transformante, quimerico,beta | |
| DE3889398D1 (de) | Verfahren zur Herstellung eines Supraleiters. | |
| ES2059492T3 (es) | Procedimiento para la preparacion de ibuprofen. | |
| NO177500C (no) | Fremgangsmåte til fremstilling av en terapeutisk aktiv hirudinvariant | |
| HUT45499A (en) | Process for producing optically active 1,4-dihydropyridine derivatives | |
| FR2614790B1 (fr) | Nouvelle composition ophtalmologique a base d'acide eicosapeutaenoique | |
| PT91006A (pt) | Processo para a preparacao de um novo sal de estroncio | |
| ATA302677A (de) | Verfahren zur herstellung von neuen 1,3-dihydro- heteroarylspiro/isobenzofuran)en und von deren optischen antipoden und pharmazeutisch vertraeglichen saeureadditionssalzen | |
| DE3382618D1 (de) | Verfahren zur herstellung von(d)2-(6-methoxy-2-naphthyl)propionsaeure und pharmazeutisch verwendbaren salzen davon und neue zwischenprodukte. | |
| HUT44126A (en) | Herbicide composition containing pyridine-monocarboxylic acid derivative with sulfur-containing group at the 5th position as active component and process for producing the active component | |
| AT361906B (de) | Verfahren zur herstellung von neuen 2,4,6- trijodbenzonitrilen sowie deren estern, saeure- amiden und salzen | |
| EP0427396A3 (en) | Optically active fluorine-containing 3-hydroxybutyric acid esters and process for producing same | |
| HUT47514A (en) | Process for racemizing optically active chrisanthemic acid and derivatives | |
| AT375940B (de) | Verfahren zur herstellung neuer 10-halogen-14-oxo-15-hydroxy-e-homoeburnane (3 alpha,17 alpha) sowie deren epimeren, optisch aktiven antipoden und physiologisch vertraeglichen saeureadditionssalze | |
| DE3851942D1 (de) | Verfahren zur Herstellung von optisch aktiver alpha-Isopropyl-p-chlorophenylessigsäure. | |
| ATA18878A (de) | Verfahren zur herstellung von (1,1-dithienyl- -(3-propen-(1)-yl-(3))-(1-phenyl-1-hydroxyproyl -(2))-amin und dessen saeureadditionssalzen und optisch aktiven isomeren | |
| NO166413C (no) | Fremgangsmaate ved anvendelse av et anlegg for direkte destillasjon i kombinasjon med en hydrostrippingsprosess. | |
| ATE129706T1 (de) | Verfahren zur direkten und regioselektiven funktionalisierung in stelle 2 von phenothiazin. | |
| DE3564260D1 (en) | 2-phenylpropionic acid esters, method for optical resolution thereof and optically active substance thereof |